Literature DB >> 15252714

[The clinical value of Holter ECG recording].

L Seipel1.   

Abstract

The Holter ECG is a well established clinical tool to document intermittent arrhythmias. The main indications are palpitations and syncope. However, the occurrence of these events during 24 h recording is very rare. So, it is often a matter of definition, what findings can speculatively "explain" a syncope. Therefore, an event recorder is often more successful. In addition, in patients with organic heart disease and reduced left ventricular function invasive electrophysiologic testing may be more appropriate. In these cases prophylactic implantation of an ICD may be indicated to prevent sudden death. So, in many instances the clinical value of Holter recording is overestimated.

Entities:  

Mesh:

Year:  2004        PMID: 15252714     DOI: 10.1007/s00108-004-1252-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  8 in total

1.  ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography).

Authors:  M H Crawford; S J Bernstein; P C Deedwania; J P DiMarco; K J Ferrick; A Garson; L A Green; H L Greene; M J Silka; P H Stone; C M Tracy; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; G Gregoratos; R O Russell; T J Ryan; S C Smith
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Guidelines on management (diagnosis and treatment) of syncope.

Authors:  M Brignole; P Alboni; D Benditt; L Bergfeldt; J J Blanc; P E Bloch Thomsen; J G van Dijk; A Fitzpatrick; S Hohnloser; J Janousek; W Kapoor; R A Kenny; P Kulakowski; A Moya; A Raviele; R Sutton; G Theodorakis; W Wieling
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

3.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

4.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

5.  Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping.

Authors:  D Lacroix; M Dubuc; T Kus; P Savard; M Shenasa; R Nadeau
Journal:  Am Heart J       Date:  1991-11       Impact factor: 4.749

6.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

7.  Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease.

Authors:  M Brodsky; D Wu; P Denes; C Kanakis; K M Rosen
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

8.  Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm.

Authors:  A A Quyyumi; L Mockus; C Wright; K M Fox
Journal:  Br Heart J       Date:  1985-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.